Severe Acute Respiratory Coronavirus Virus 2 (Sars-Cov-2) Delta Variant of Concern Breakthrough Infections: Are Vaccines Failing Us?

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

Severe Acute Respiratory Coronavirus Virus 2 (Sars-Cov-2) Delta Variant of Concern Breakthrough Infections: Are Vaccines Failing Us? Publisher Pubmed

Nowroozi A^{1, 2} ; Rezaei N^{2, 3, 4}

Show Affiliations

1. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
2. Network of Immunity in Infection Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
3. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
4. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Infection Control and Hospital Epidemiology Published:2022

Abstract

[No abstract available]

Style	Citing Format
MLA	Nowroozi A, Rezaei N. "Severe Acute Respiratory Coronavirus Virus 2 (Sars-Cov-2) Delta Variant of Concern Breakthrough Infections: Are Vaccines Failing Us?." Infection Control and Hospital Epidemiology, vol. 43, no. 11, 2022, pp. 1754-1755.
APA	Nowroozi A, Rezaei N (2022). Severe Acute Respiratory Coronavirus Virus 2 (Sars-Cov-2) Delta Variant of Concern Breakthrough Infections: Are Vaccines Failing Us?. Infection Control and Hospital Epidemiology, 43(11), 1754-1755.
Chicago	Nowroozi A, Rezaei N. "Severe Acute Respiratory Coronavirus Virus 2 (Sars-Cov-2) Delta Variant of Concern Breakthrough Infections: Are Vaccines Failing Us?." Infection Control and Hospital Epidemiology 43, no. 11 (2022): 1754-1755.
Harvard	Nowroozi A, Rezaei N (2022) 'Severe Acute Respiratory Coronavirus Virus 2 (Sars-Cov-2) Delta Variant of Concern Breakthrough Infections: Are Vaccines Failing Us?', Infection Control and Hospital Epidemiology, 43(11), pp. 1754-1755.
Vancouver	Nowroozi A, Rezaei N. Severe Acute Respiratory Coronavirus Virus 2 (Sars-Cov-2) Delta Variant of Concern Breakthrough Infections: Are Vaccines Failing Us?. Infection Control and Hospital Epidemiology. 2022;43(11):1754-1755.
BibTex	@article{ author = {Nowroozi A and Rezaei N}, title = {Severe Acute Respiratory Coronavirus Virus 2 (Sars-Cov-2) Delta Variant of Concern Breakthrough Infections: Are Vaccines Failing Us?}, journal = {Infection Control and Hospital Epidemiology}, volume = {43}, number = {11}, pages = {1754-1755}, year = {2022} }
RIS	TY - JOUR AU - Nowroozi A AU - Rezaei N TI - Severe Acute Respiratory Coronavirus Virus 2 (Sars-Cov-2) Delta Variant of Concern Breakthrough Infections: Are Vaccines Failing Us? JO - Infection Control and Hospital Epidemiology VL - 43 IS - 11 SP - 1754 EP - 1755 PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract